Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/22/24 07:30:08 on US and Canada Markets.
First Quarter 2024 Performance and Operational Highlights Net income of $8.1 million, or $0.90 per diluted share Core net income (1) of $8.1 million, or $0.90 per diluted share (1) Net interest income of $ 20.8 ...
Innovative Collaboration Between Draganfly, Doodle Labs, and UXV Technologies Sets New Standards for UAV Operations San Diego, CA., April 22, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award...
First Quarter Net Revenue Range Improved to $20.0 Million to $21.0 Million First Quarter Adjusted EBITDA Loss Range Improved to ($2.4) Million to ($2.9) Million NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Co...
(NewsDirect) NEW YORK, NY / NewsDirect / April 22nd, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of rec...
Ranpak’s RecyCold ® climaliner Plus™ and naturemailer™ solutions provide paper-based alternatives to legacy packaging solutions Ranpak Holdings Corp . (“Ranpak”) (NYSE: PACK) a global leader in sustainable packaging, today announced the Nort...
(NewsDirect) NEW YORK, NY / NewsDirect / April 22nd, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of rec...
B. Riley Farber Expands Western Canada Restructuring Practice with Senior Hire Canada NewsWire Ryan Adlington, veteran restructuring and turnaround expert, joins B. Riley as Senior Managing Director CALGARY, AB and LOS ANGELES , April 22, 2024 /C...
– Ziftomenib is the first investigational treatment to be granted Breakthrough Therapy Designation for NPM1-mutant AML – – Registration-directed trial of ziftomenib in NPM1-mutant AML on track to complete enrollment by mid-2024 – SAN DIEGO, April 22, 2024 (GLOB...
TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Company”) announced today that two of its subsidiaries and a trust controlled by Dundee (collectively, the “Dundee Entities”) entered into Voting Support Agre...
TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Company”) announced today that two of its subsidiaries and a trust controlled by Dundee (collectively, the “Dundee Entities”) entered into Voting Support Agre...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
17.47%Change Percent:
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
medpace.com Website: